275 related articles for article (PubMed ID: 25629941)
1. Protective effects of cholecystokinin-8 on methamphetamine-induced behavioral changes and dopaminergic neurodegeneration in mice.
Gou H; Wen D; Ma C; Li M; Li Y; Zhang W; Liu L; Cong B
Behav Brain Res; 2015 Apr; 283():87-96. PubMed ID: 25629941
[TBL] [Abstract][Full Text] [Related]
2. Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine.
Granado N; Ares-Santos S; O'Shea E; Vicario-Abejón C; Colado MI; Moratalla R
Neurotox Res; 2010 Jul; 18(1):48-58. PubMed ID: 19760475
[TBL] [Abstract][Full Text] [Related]
3. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.
Itzhak Y; Gandia C; Huang PL; Ali SF
J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865
[TBL] [Abstract][Full Text] [Related]
4. Protective and restorative effects of the traditional Chinese medicine Jitai tablet against methamphetamine-induced dopaminergic neurotoxicity.
Xu S; Tu S; Gao J; Liu J; Guo Z; Zhang J; Liu X; Liang J; Huang Y; Han M
BMC Complement Altern Med; 2018 Feb; 18(1):76. PubMed ID: 29475448
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
[TBL] [Abstract][Full Text] [Related]
6. Mithramycin protects against dopaminergic neurotoxicity in the mouse brain after administration of methamphetamine.
Hagiwara H; Iyo M; Hashimoto K
Brain Res; 2009 Dec; 1301():189-96. PubMed ID: 19748494
[TBL] [Abstract][Full Text] [Related]
7. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
Killinger BA; Moszczynska A
J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
[TBL] [Abstract][Full Text] [Related]
8. 9-Cis retinoic acid protects against methamphetamine-induced neurotoxicity in nigrostriatal dopamine neurons.
Reiner DJ; Yu SJ; Shen H; He Y; Bae E; Wang Y
Neurotox Res; 2014 Apr; 25(3):248-61. PubMed ID: 23884514
[TBL] [Abstract][Full Text] [Related]
9. Attenuated methamphetamine induced neurotoxicity by modafinil administration in mice.
Raineri M; Peskin V; Goitia B; Taravini IR; Giorgeri S; Urbano FJ; Bisagno V
Synapse; 2011 Oct; 65(10):1087-98. PubMed ID: 21590747
[TBL] [Abstract][Full Text] [Related]
10. Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration.
Choi DY; Lee MK; Hong JT
Neurobiol Dis; 2013 Jan; 49():159-68. PubMed ID: 22922220
[TBL] [Abstract][Full Text] [Related]
11. A new poly(ADP-ribose) polymerase inhibitor, FR261529 [2-(4-chlorophenyl)-5-quinoxalinecarboxamide], ameliorates methamphetamine-induced dopaminergic neurotoxicity in mice.
Iwashita A; Mihara K; Yamazaki S; Matsuura S; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Sep; 310(3):1114-24. PubMed ID: 15113847
[TBL] [Abstract][Full Text] [Related]
12. Differential action of methamphetamine on tyrosine hydroxylase and dopamine transport in the nigrostriatal pathway of μ-opioid receptor knockout mice.
Park SW; He Z; Shen X; Roman RJ; Ma T
Int J Neurosci; 2012 Jun; 122(6):305-13. PubMed ID: 22329540
[TBL] [Abstract][Full Text] [Related]
13. Tissue plasminogen activator is not involved in methamphetamine-induced neurotoxicity.
Fukakusa A; Mizoguchi H; Koike H; Nabeshima T; Takuma K; Yamada K
J Pharmacol Sci; 2008 Feb; 106(2):321-4. PubMed ID: 18277051
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity.
Liu B; Traini R; Killinger B; Schneider B; Moszczynska A
Exp Neurol; 2013 Sep; 247():359-72. PubMed ID: 23313192
[TBL] [Abstract][Full Text] [Related]
15. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
16. Behavioral consequences of methamphetamine-induced neurotoxicity in mice: relevance to the psychopathology of methamphetamine addiction.
Itzhak Y; Ali SF
Ann N Y Acad Sci; 2002 Jun; 965():127-35. PubMed ID: 12105090
[TBL] [Abstract][Full Text] [Related]
17. Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining.
Ares-Santos S; Granado N; Espadas I; Martinez-Murillo R; Moratalla R
Neuropsychopharmacology; 2014 Apr; 39(5):1066-80. PubMed ID: 24169803
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine.
Zhang L; Kitaichi K; Fujimoto Y; Nakayama H; Shimizu E; Iyo M; Hashimoto K
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1381-93. PubMed ID: 16839653
[TBL] [Abstract][Full Text] [Related]
19. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of environment-induced changes in body temperature on modafinil's actions against methamphetamine-induced striatal toxicity in mice.
Raineri M; González B; Rivero-Echeto C; Muñiz JA; Gutiérrez ML; Ghanem CI; Cadet JL; García-Rill E; Urbano FJ; Bisagno V
Neurotox Res; 2015 Jan; 27(1):71-83. PubMed ID: 25261212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
